RTX
ACCE-researchedRTX Corporation Common Stock
Industrials · Aerospace & Defense · NYSE · United States
$197.55-0.63%
Market cap $266.2BNext earnings 2026-10-20Updated Sep 9, 2026
FAIR VALUE · 6-MODEL CONSENSUS
$197.55+0.0%
confidence-weighted across 6 models
Now $197.55
$197.55
$73.16$174.75
AvoidBronze45
Free accounts get 3 full stock pages a month, including FAIR VALUE · 6-MODEL CONSENSUS.
Unlock the ACCE read
Free accounts get 3 full stock pages a month, including the ACCE read.
ACCE thesis
RTX manufactures jet engines, defense missiles, and aerospace systems through Pratt & Whitney, Raytheon, and Collins Aerospace divisions. The company dominates commercial engine aftermarket services with 70%+ margins and multi-decade revenue visibility as airlines expand fleets globally. Pentagon spending acceleration and NATO defense budget increases following Ukraine create a multi-year tailwind for the Raytheon missile portfolio. Trading at 26x forward earnings despite sitting on a $200 billion commercial aerospace backlog that stretches into the 2030s. Free cash flow generation should accelerate meaningfully as supply chain constraints ease and aftermarket revenues compound.
⚠ Investor warnings · 4 flags
- highStock above fair valueCurrent price $195.78 exceeds model fair value $180 and sits above the top of the $165.60-$194.40 fair value range.
- highHeavy insider sellingLast 10 disclosed transactions show $40.64M in sales and $0 in buys - entirely one-directional insider distribution.
- moderateQoQ revenue decelerationSequential quarterly revenue declined 8.9% despite strong YoY growth of 8.7%, signalling potential near-term momentum slowdown.
- moderateStretched valuation multiplesP/E of 36.8x and EV/EBITDA of 19.2x are elevated for a low-single-digit 5-year revenue CAGR of 4.5%.
Reports in 40 days, last quarter beat by 0.1%.
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
Price
+27.5% · 1Y
Snapshot
Valuation
Trailing P/E
34.7x
Forward P/E
25.1x
PEG
1.23
P/B
4.10x
EV / Revenue
3.2x
Book value/sh
$49.25
Enterprise value
$303.0B
Profitability
ROE
12.3%
FCF yield
2.93%
ROIC
5.4%
Health and risk
Debt / equity
0.58
Dividend yield
1.47%
Beta
0.29